Indeed, cytoplasmic FtH in breast cancer cells regulates the MHC-I-mediated antigen processing and presentation, thus consequently inducing the recall of CD8+ T cells, whereas nuclear FtH promotes cancer cells viability [112]. The gene discussed is CD8A; the disease is cancer.